Skip to main content
Top
Published in: Social Indicators Research 2/2016

19-07-2015

Measuring Interstate Variations in the Consequences of Illegal Drugs: A Composite Indicator Approach

Authors: Eric L. Sevigny, Michaela Saisana

Published in: Social Indicators Research | Issue 2/2016

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

This study develops a series of Drug Consequences Indices (DCIs) measuring interstate variations in the harmful consequences of heroin, methamphetamine, cocaine, and marijuana in the US from 2000 to 2009. Indicators measuring drug-related health, social and economic, and crime and disorder consequences were selected from key drug data systems. Using weights derived from an Analytic Hierarchy Process conducted with addiction and drug policy experts, indicators were normalized by min–max scaling and aggregated using geometric means to produce each drug-specific DCI. Index scores were generated on a best–worst scale of 0–100 for all 50 states across 10 years. The Heroin Consequences Index reveals a general uptick in heroin-related problems, but the most severely impacted states fall in the Northeast. The Methamphetamine Consequences Index reveals that the worst affected states lay west of the Mississippi River and confirms the methamphetamine problem peaked about mid-decade. The Cocaine Consequences Index also shows a general decline beginning mid-decade, but in contrast to methamphetamine the most impacted states lay along the Gulf and East Coasts. The Marijuana Consequences Index in contrast is neither highly regionalized nor consistently trending. The DCIs provide a parsimonious yet comprehensive snapshot of geographic and temporal variations in the nature and extent of illicit drug problems. They have a number of practical applications, including the ability to succinctly communicate drug policy needs, objectives, and progress at the national, regional, and state levels. Other policy applications include aiding benchmarking, performance assessment, and resource allocation decisions.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Appendix
Available only for authorised users
Footnotes
1
We contacted 36 individuals representing a cross-section of backgrounds and expertise: 19 agreed to participate, 3 agreed to participate but were unable to fulfill their commitment, 3 declined, and 11 could not be reached or did not respond to the invitation.
 
2
The choice of the geometric mean, as opposed to the classical arithmetic average, is driven by both conceptual and methodological purposes. Conceptually, perfect substitutability among the index components (as occurs with the arithmetic average) is not desirable. Substitutability (or compensability) is understood here as the undesirable offsetting of poor performance on some indicators with good performance on others. Methodologically, the use of arithmetic average would have been problematic because it would have implied that the level of priority given to a dimension of drug consequences is invariant to the level of attainment. Instead, the geometric mean gives more incentives for improvement to low values (concave function). This explains the orientation of normalized values in Eq. (1) First, in order to derive participatory-driven weights for use in constructing the DCIs, we geometric mean with a double change of orientation was preferred over a simple generalized mean of power 2 for two reasons that are specific to our context: (a) consistency between the nominal weights assigned to the three main dimensions and their “importance” or main effects (see Sect. 3.6) and (b) greater variation in the index scores across the four drug types.
 
3
For example, in the Crime and Disorder domain for the Cocaine Consequences Index, there are no indicators for ‘community and environmental harms.’ Thus, the weights for the ‘drugged driving’ and ‘crime and nuisance’ subdomains were rescaled to .056 = (.04 + (.04/.388)) * .388 and .325 = (.234 + (.234/.388)) * .388, respectively, and finally to .147 = (.056/(.056 + .325) and 0.853 = (.325/(.056 + .325).
 
4
These index subcomponents are downloadable as a data supplement from the journal’s website.
 
5
Note that in our context, the use of a generalized mean of power 2 would have altered the order of importance of the three main dimensions in the various drug types.
 
6
A methodological break in the NSDUH sampling design precludes comparison with pre-2002 data. Aggregate 2002–2009 data facilitate more table state-level estimates, especially for heroin and methamphetamine.
 
Literature
go back to reference Babor, T., Caulkins, J., Edwards, G., Fischer, B., Foxcroft, D., Humphreys, K., et al. (2010). Drug policy and the public good. Oxford: Oxford University Press. Babor, T., Caulkins, J., Edwards, G., Fischer, B., Foxcroft, D., Humphreys, K., et al. (2010). Drug policy and the public good. Oxford: Oxford University Press.
go back to reference Brand, D. A., Saisana, M., Rynn, L. A., Pennoni, F., & Lowenfels, A. B. (2007). Comparative analysis of alcohol control policies in 30 countries. PLoS Med, 4(4), 752–759.CrossRef Brand, D. A., Saisana, M., Rynn, L. A., Pennoni, F., & Lowenfels, A. B. (2007). Comparative analysis of alcohol control policies in 30 countries. PLoS Med, 4(4), 752–759.CrossRef
go back to reference Caulkins, J. P., Kasunic, A., Kleiman, M., & Lee, M. A. C. (2014). Societal burden of substance abuse. International Public Health Journal, 6(3), 269–282. Caulkins, J. P., Kasunic, A., Kleiman, M., & Lee, M. A. C. (2014). Societal burden of substance abuse. International Public Health Journal, 6(3), 269–282.
go back to reference Coffey, R. M., Levit, K. R., Kassed, C. A., McLellan, A. T., Chalk, M., Brady, T. M., et al. (2009). Evidence for substance abuse services and policy research: A systematic review of national databases. Evaluation Review, 33(2), 103–137.CrossRef Coffey, R. M., Levit, K. R., Kassed, C. A., McLellan, A. T., Chalk, M., Brady, T. M., et al. (2009). Evidence for substance abuse services and policy research: A systematic review of national databases. Evaluation Review, 33(2), 103–137.CrossRef
go back to reference Collins, J. J., & Zawitz, M. W. (1990). Federal drug data for national policy. Washington, DC: Bureau of Justice Statistics. Collins, J. J., & Zawitz, M. W. (1990). Federal drug data for national policy. Washington, DC: Bureau of Justice Statistics.
go back to reference CSR Incorporated. (2008). Alcohol epidemiologic data directory. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism. CSR Incorporated. (2008). Alcohol epidemiologic data directory. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism.
go back to reference Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., et al. (2009). High-potency cannabis and the risk of psychosis. The British Journal of Psychiatry, 195(6), 488–491. doi:10.1192/bjp.bp.109.064220.CrossRef Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., et al. (2009). High-potency cannabis and the risk of psychosis. The British Journal of Psychiatry, 195(6), 488–491. doi:10.​1192/​bjp.​bp.​109.​064220.CrossRef
go back to reference Ebener, P. A., Feldman, E., & Fitzgerald, N. (1993). Federal databases for use in drug policy research: A catalog for data users. Santa Monica, CA: RAND. Ebener, P. A., Feldman, E., & Fitzgerald, N. (1993). Federal databases for use in drug policy research: A catalog for data users. Santa Monica, CA: RAND.
go back to reference European Monitoring Centre for Drugs and Drug Addiction. (2009). Risk assessment of new psychoactive substances: Operating guidelines. Luxembourg: The Publications Office of the European Union. European Monitoring Centre for Drugs and Drug Addiction. (2009). Risk assessment of new psychoactive substances: Operating guidelines. Luxembourg: The Publications Office of the European Union.
go back to reference Garnick, D. W., Hodgkin, D., & Horgan, C. M. (2002). Selecting data sources for substance abuse services research. Journal of Substance Abuse Treatment, 22(1), 11–22.CrossRef Garnick, D. W., Hodgkin, D., & Horgan, C. M. (2002). Selecting data sources for substance abuse services research. Journal of Substance Abuse Treatment, 22(1), 11–22.CrossRef
go back to reference Gonzales, R., Mooney, L., & Rawson, R. A. (2010). The methamphetamine problem in the United States. Annual Review of Public Health, 31(1), 385–398.CrossRef Gonzales, R., Mooney, L., & Rawson, R. A. (2010). The methamphetamine problem in the United States. Annual Review of Public Health, 31(1), 385–398.CrossRef
go back to reference Hall, W., & Degenhardt, L. (2011). What are the policy implications of the evidence on cannabis and psychosis? In D. Castle, R. M. Murray, & D. C. D’Souza (Eds.), Marijuana and madness (pp. 55–65). Cambridge: Cambridge University Press.CrossRef Hall, W., & Degenhardt, L. (2011). What are the policy implications of the evidence on cannabis and psychosis? In D. Castle, R. M. Murray, & D. C. D’Souza (Eds.), Marijuana and madness (pp. 55–65). Cambridge: Cambridge University Press.CrossRef
go back to reference Hirshon, J. M., Warner, M., Irvin, C. B., Niska, R. W., Andersen, D. A., Smith, G. S., et al. (2009). Research using emergency department-related data sets: Current status and future directions. Academic Emergency Medicine, 16(11), 1103–1109.CrossRef Hirshon, J. M., Warner, M., Irvin, C. B., Niska, R. W., Andersen, D. A., Smith, G. S., et al. (2009). Research using emergency department-related data sets: Current status and future directions. Academic Emergency Medicine, 16(11), 1103–1109.CrossRef
go back to reference Home Office. (2009). Measuring the harm from illegal drugs: A summary of the drug harm index 2006. London: Research Development and Statistics Directorate, Home Office. Home Office. (2009). Measuring the harm from illegal drugs: A summary of the drug harm index 2006. London: Research Development and Statistics Directorate, Home Office.
go back to reference Honaker, J., & King, G. (2010). What to do about missing values in time-series cross-section data. American Journal of Political Science, 54(2), 561–581.CrossRef Honaker, J., & King, G. (2010). What to do about missing values in time-series cross-section data. American Journal of Political Science, 54(2), 561–581.CrossRef
go back to reference Honaker, J., King, G., & Blackwell, M. (2012). AMELIA II: A program for missing data. Cambridge, MA: Harvard University. Honaker, J., King, G., & Blackwell, M. (2012). AMELIA II: A program for missing data. Cambridge, MA: Harvard University.
go back to reference King, G., Honaker, J., Joseph, A., & Scheve, K. (2001). Analyzing incomplete political science data: An alternative algorithm for multiple imputation. American Political Science Review, 95(1), 49–70. King, G., Honaker, J., Joseph, A., & Scheve, K. (2001). Analyzing incomplete political science data: An alternative algorithm for multiple imputation. American Political Science Review, 95(1), 49–70.
go back to reference Levitt, R., Nason, E., & Hallsworth, M. (2006). The evidence base for the classification of drugs. Cambridge, UK: RAND Europe. Levitt, R., Nason, E., & Hallsworth, M. (2006). The evidence base for the classification of drugs. Cambridge, UK: RAND Europe.
go back to reference Longshore, D., Reuter, P., Derks, J., Grapendaal, M., & Ebener, P. (1998). Drug policies and harms: A conceptual framework. European Addiction Research, 4(4), 172–182.CrossRef Longshore, D., Reuter, P., Derks, J., Grapendaal, M., & Ebener, P. (1998). Drug policies and harms: A conceptual framework. European Addiction Research, 4(4), 172–182.CrossRef
go back to reference MacCoun, R. J., & Reuter, P. (2001). Drug war heresies: Learning from other vices, times, and places. New York: Cambridge University Press.CrossRef MacCoun, R. J., & Reuter, P. (2001). Drug war heresies: Learning from other vices, times, and places. New York: Cambridge University Press.CrossRef
go back to reference MacDonald, Z., Tinsley, L., Collingwood, J., Jamieson, P., & Pudney, S. (2005). Measuring the harm from illegal drugs using the drug harm index. London: Research Development and Statistics Directorate, Home Office.CrossRef MacDonald, Z., Tinsley, L., Collingwood, J., Jamieson, P., & Pudney, S. (2005). Measuring the harm from illegal drugs using the drug harm index. London: Research Development and Statistics Directorate, Home Office.CrossRef
go back to reference Maxwell, J. C., & Rutkowski, B. A. (2008). The prevalence of methamphetamine and amphetamine abuse in North America: A review of the indicators, 1992–2007. Drug and Alcohol Review, 27(3), 229–235.CrossRef Maxwell, J. C., & Rutkowski, B. A. (2008). The prevalence of methamphetamine and amphetamine abuse in North America: A review of the indicators, 1992–2007. Drug and Alcohol Review, 27(3), 229–235.CrossRef
go back to reference McAuliffe, W. E., & Dunn, R. P. (2004). Substance abuse treatment needs and access in the USA: Interstate variations. Addiction, 99(8), 999–1014.CrossRef McAuliffe, W. E., & Dunn, R. P. (2004). Substance abuse treatment needs and access in the USA: Interstate variations. Addiction, 99(8), 999–1014.CrossRef
go back to reference McAuliffe, W. E., LaBrie, R., Lomuto, N., Betjemann, R., & Fournier, E. (1999). Measuring interstate variations in drug problems. Drug and Alcohol Dependence, 53, 125–145.CrossRef McAuliffe, W. E., LaBrie, R., Lomuto, N., Betjemann, R., & Fournier, E. (1999). Measuring interstate variations in drug problems. Drug and Alcohol Dependence, 53, 125–145.CrossRef
go back to reference McAuliffe, W. E., LaBrie, R., Woodworth, R., Zhang, C., & Dunn, R. P. (2003). State substance abuse treatment gaps. American Journal on Addictions, 12(2), 101–121.CrossRef McAuliffe, W. E., LaBrie, R., Woodworth, R., Zhang, C., & Dunn, R. P. (2003). State substance abuse treatment gaps. American Journal on Addictions, 12(2), 101–121.CrossRef
go back to reference McFadden, M. (2006). The Australian Federal Police Drug Harm Index: A new methodology for quantifying success in combating drug use. Australian Journal of Public Administration, 65(4), 68–81.CrossRef McFadden, M. (2006). The Australian Federal Police Drug Harm Index: A new methodology for quantifying success in combating drug use. Australian Journal of Public Administration, 65(4), 68–81.CrossRef
go back to reference Miller, T. R., Levy, D. T., Cohen, M. A., & Cox, K. L. C. (2006). Costs of alcohol and drug-involved crime. Prevention Sciences, 7, 333–342.CrossRef Miller, T. R., Levy, D. T., Cohen, M. A., & Cox, K. L. C. (2006). Costs of alcohol and drug-involved crime. Prevention Sciences, 7, 333–342.CrossRef
go back to reference National Drug Intelligence Center. (2011). The economic impact of illicit drug use on American society. Washington D.C.: United States Department of Justice. National Drug Intelligence Center. (2011). The economic impact of illicit drug use on American society. Washington D.C.: United States Department of Justice.
go back to reference National Institute on Drug Abuse. (2006). Assessing drug abuse within and across communities: Community epidemiology surveillance networks on drug abuse (2nd ed.). Bethesda, MD: National Institutes of Health. National Institute on Drug Abuse. (2006). Assessing drug abuse within and across communities: Community epidemiology surveillance networks on drug abuse (2nd ed.). Bethesda, MD: National Institutes of Health.
go back to reference National Research Council. (2001). Informing America’s policy on illegal drugs: What we don’t know keeps hurting us. Washington, DC: The National Academies Press. National Research Council. (2001). Informing America’s policy on illegal drugs: What we don’t know keeps hurting us. Washington, DC: The National Academies Press.
go back to reference National Research Council. (2010). Understanding the demand for illegal drugs. Washington, DC: The National Academies Press. National Research Council. (2010). Understanding the demand for illegal drugs. Washington, DC: The National Academies Press.
go back to reference Nicosia, N., Pacula, R., Kilmer, B., Lundberg, R., & Chiesa, J. (2009). The economic cost of methamphetamine use in the United States, 2005. Santa Monica, CA: RAND. Nicosia, N., Pacula, R., Kilmer, B., Lundberg, R., & Chiesa, J. (2009). The economic cost of methamphetamine use in the United States, 2005. Santa Monica, CA: RAND.
go back to reference Nutt, D. J., King, L. A., & Phillips, L. D. (2010). Drug harms in the UK: A multicriteria decision analysis. The Lancet, 376(9752), 1558–1565.CrossRef Nutt, D. J., King, L. A., & Phillips, L. D. (2010). Drug harms in the UK: A multicriteria decision analysis. The Lancet, 376(9752), 1558–1565.CrossRef
go back to reference Nutt, D. J., King, L. A., Saulsbury, W., & Blakemore, C. (2007). Development of a rational scale to assess the harm of drugs of potential misuse. Lancet, 369, 1047–1053.CrossRef Nutt, D. J., King, L. A., Saulsbury, W., & Blakemore, C. (2007). Development of a rational scale to assess the harm of drugs of potential misuse. Lancet, 369, 1047–1053.CrossRef
go back to reference Office of National Drug Control Policy. (1990). Leading drug indicators. Washington, DC: Executive Office of the President. Office of National Drug Control Policy. (1990). Leading drug indicators. Washington, DC: Executive Office of the President.
go back to reference Office of National Drug Control Policy. (2003). Federal Drug-Related Data Systems Inventory: Report of the Drug Control Research, Data, and Evaluation Committee. Washington, DC: Executive Office of the President. Office of National Drug Control Policy. (2003). Federal Drug-Related Data Systems Inventory: Report of the Drug Control Research, Data, and Evaluation Committee. Washington, DC: Executive Office of the President.
go back to reference Office of National Drug Control Policy. (2004). The economic costs of drug abuse in the United States, 1992–2002. Washington, DC: Executive Office of the President.CrossRef Office of National Drug Control Policy. (2004). The economic costs of drug abuse in the United States, 1992–2002. Washington, DC: Executive Office of the President.CrossRef
go back to reference Organisation for Economic Co-operation and Development. (2008). Handbook on constructing composite indicators: Methodology and user guide. Paris: OECD Publishing. Organisation for Economic Co-operation and Development. (2008). Handbook on constructing composite indicators: Methodology and user guide. Paris: OECD Publishing.
go back to reference Paruolo, P., Saisana, M., & Saltelli, A. (2013). Ratings and rankings: Voodoo or science? Journal of the Royal Statistical Society: Series A (Statistics in Society), 176(3), 609–634.CrossRef Paruolo, P., Saisana, M., & Saltelli, A. (2013). Ratings and rankings: Voodoo or science? Journal of the Royal Statistical Society: Series A (Statistics in Society), 176(3), 609–634.CrossRef
go back to reference Paschall, M. J., Grube, J. W., & Kypri, K. (2009). Alcohol control policies and alcohol consumption by youth: A multi-national study. Addiction, 104(11), 1849–1855.CrossRef Paschall, M. J., Grube, J. W., & Kypri, K. (2009). Alcohol control policies and alcohol consumption by youth: A multi-national study. Addiction, 104(11), 1849–1855.CrossRef
go back to reference Ritter, A. (2009). Methods for comparing drug policies—The utility of composite drug harm indexes. International Journal of Drug Policy, 20(6), 475–479.CrossRef Ritter, A. (2009). Methods for comparing drug policies—The utility of composite drug harm indexes. International Journal of Drug Policy, 20(6), 475–479.CrossRef
go back to reference Rootman, I., & Hughes, P. H. (1980). Drug-abuse reporting systems. Geneva: World Health Organization. Rootman, I., & Hughes, P. H. (1980). Drug-abuse reporting systems. Geneva: World Health Organization.
go back to reference Saaty, T. L. (1980). The analytic hierarchy process. New York: McGraw-Hill. Saaty, T. L. (1980). The analytic hierarchy process. New York: McGraw-Hill.
go back to reference Saaty, T. L. (2005). The analytic hierarchy and analytic network processes for the measurement of intangible criteria and for decision-making. In J. Figueira, S. Greco, & M. Ehrogott (Eds.), Multiple criteria decision analysis: State of the art surveys (pp. 345–405). New York: Springer. Saaty, T. L. (2005). The analytic hierarchy and analytic network processes for the measurement of intangible criteria and for decision-making. In J. Figueira, S. Greco, & M. Ehrogott (Eds.), Multiple criteria decision analysis: State of the art surveys (pp. 345–405). New York: Springer.
go back to reference Saaty, T. L., & Vargas, L. G. (2001). The seven pillars of the analytic hierarchy process. In T. L. Saaty & L. G. Vargas (Eds.), Models, methods, concepts & applications of the analytic hierarchy process (pp. 27–46). New York: Springer.CrossRef Saaty, T. L., & Vargas, L. G. (2001). The seven pillars of the analytic hierarchy process. In T. L. Saaty & L. G. Vargas (Eds.), Models, methods, concepts & applications of the analytic hierarchy process (pp. 27–46). New York: Springer.CrossRef
go back to reference Saisana, M., d’Hombres, B., & Saltelli, A. (2011). Rickety numbers: Volatility of university rankings and policy implications. Research Policy, 40(1), 165–177.CrossRef Saisana, M., d’Hombres, B., & Saltelli, A. (2011). Rickety numbers: Volatility of university rankings and policy implications. Research Policy, 40(1), 165–177.CrossRef
go back to reference Saisana, M., Saltelli, A., & Tarantola, S. (2005). Uncertainty and sensitivity techniques as tools for the analysis and validation of composite indicators. Journal of the Royal Statistical Society A, 168(2), 307–323.CrossRef Saisana, M., Saltelli, A., & Tarantola, S. (2005). Uncertainty and sensitivity techniques as tools for the analysis and validation of composite indicators. Journal of the Royal Statistical Society A, 168(2), 307–323.CrossRef
go back to reference Sevigny, E. L., & Saisana, M. (2013). Developing the US Drug Consequences Indices, 2000–2009. Washington, DC: Executive Office of the President. Sevigny, E. L., & Saisana, M. (2013). Developing the US Drug Consequences Indices, 2000–2009. Washington, DC: Executive Office of the President.
go back to reference Slack, A., O’Dea, D., Sheerin, I., Norman, D., Wu, J., & Nana, G. (2008). New Zealand Drug Harm Index. Wellington, New Zealand: BERL. Slack, A., O’Dea, D., Sheerin, I., Norman, D., Wu, J., & Nana, G. (2008). New Zealand Drug Harm Index. Wellington, New Zealand: BERL.
go back to reference United Nations Office on Drugs and Crime. (2005). 2005 World Drug Report. Vienna: UNODC. United Nations Office on Drugs and Crime. (2005). 2005 World Drug Report. Vienna: UNODC.
go back to reference US Burden of Disease Collaborators. (2013). The state of US health, 1990–2010: Burden of diseases, injuries, and risk factors. JAMA, 310(6), 591–606.CrossRef US Burden of Disease Collaborators. (2013). The state of US health, 1990–2010: Burden of diseases, injuries, and risk factors. JAMA, 310(6), 591–606.CrossRef
go back to reference Vaidya, O. S., & Kumar, S. (2006). Analytic hierarchy process: An overview of applications. European Journal of Operational Research, 169(1), 1–29.CrossRef Vaidya, O. S., & Kumar, S. (2006). Analytic hierarchy process: An overview of applications. European Journal of Operational Research, 169(1), 1–29.CrossRef
go back to reference van Amsterdam, J., Best, W., Opperhuizen, A., & de Wolff, F. A. (2004). Evaluation of a procedure to assess the adverse effects of illicit drugs. Regulatory Toxicology and Pharmacology, 39(1), 1–4.CrossRef van Amsterdam, J., Best, W., Opperhuizen, A., & de Wolff, F. A. (2004). Evaluation of a procedure to assess the adverse effects of illicit drugs. Regulatory Toxicology and Pharmacology, 39(1), 1–4.CrossRef
Metadata
Title
Measuring Interstate Variations in the Consequences of Illegal Drugs: A Composite Indicator Approach
Authors
Eric L. Sevigny
Michaela Saisana
Publication date
19-07-2015
Publisher
Springer Netherlands
Published in
Social Indicators Research / Issue 2/2016
Print ISSN: 0303-8300
Electronic ISSN: 1573-0921
DOI
https://doi.org/10.1007/s11205-015-1042-2

Other articles of this Issue 2/2016

Social Indicators Research 2/2016 Go to the issue